Updated August 31 at 6:31pm
Life Sciences
18 results total, viewing 11 - 18
(Updated, 5:14 p.m.) A Cherrystone Angel Group portfolio business has entered into an acquisition agreement of $140 million with a European buyer specializing in bio-analytical testing and genomic services. more
IlluminOss Medical has received conditional approval from the federal Food and Drug Administration to conduct a clinical trial for treatments of impending and pathologic fractures in the humerus due to metastatic carcinoma. more
Mnemosyne Pharmaceuticals Inc. appointment of Vanessa King as president and CEO. more
The Bill and Melinda Gates Foundation has awarded a $100,000 grant to the GAIA Vaccine Foundation to raise awareness about the prevention of cervical cancer in West Africa. more
Venture capital firm SV Life Sciences has acquired a majority interest in Ximedica from co-founders Stephen Lane and Aidan Petrie. more
A Japanese biopharmaceutical company has contracted to begin using a protein-screening interface developed by Providence-based EpiVax Inc. more
The Rhode Island Foundation awarded $125,000 in grants to fund work on shoreline protection and the shellfish industry by the Coastal Resources Center at the University of Rhode Island’s Graduate School of Oceanography. more
Steve Lombardi has been named CEO and president of Nabsys Inc., a life sciences company pioneering semiconductor-based tools for genomic analysis. more
« Prev | 1 | 2